Objective To clone a new liver cancer associated gene, and to explore the molecular basis of liver cancer genesis. Methods Using mRNA differential display polymerase chain reaction (DDPCR), we investigated the difference in mRNA expression between primary hepatocellular carcinoma and paracarcinoma liver tissue, and achieved a gene probe. The target gene expression was proved in parent tissue by Northern blot. Screening the placenta cDNA library, we got a full length cDNA of this gene. By GST fusion protein methods, we prepared the special polyantibody of C end of the gene. We identified the polyantibody and the expression of this gene by Western blot method. Results We obtained a full length cDNA of proline riched cancer associated gene, and we have prepared the specific polyantibody of this gene. Conclusion The obtaining of a novel liver cancer associated gene and successful preparation of the polyantibody pave the way for further study on gene therapy for liver cancer.

Objective To explore the clinical value of the serum cystatin C (Cys C) changes in different periods of the infantile pneumonia.Methods Ninety-two cases of infantile pneumonia (59 mild pneumonia patients and 33 severe pneumonia patients) from November 2012 to March 2013 were collected and 40 cases of healthy infant were enrolled for control group.The levels of serum Cys C,urea and creatinine in acute and recovery period were detected.Results In severe pneumonia patients,the average level of Cys C in acute period [(1.98±0.33) mg/L] is significantly higher than that in control group [(0.85 ±0.24) mg/L] (P ＜0.01),and there was no significant difference between recovery period [(1.12 ± 0.23) mg/L] and control group (P ＞ 0.05),and there was significant difference between acute and recovery period (P ＜0.05).In mild pneumonia patients,there were no significant differences in the level of Cys C between the acute period [(1.10 ±0.22) mg/L] and recovery period [(0.94 ±0.21) mg/L] as well as control group (P ＞ 0.05).The positive rate of Cys C in severe pneumonia patients (51.9％,14/27) was higher than that of urea and creatinine (3.7％,1/27) (P ＜0.01).Conclusion Severe pneumonia could result in renal dysfunction,which is reversible.Cys C can be the clinical reference for early diagnosis and the therapeutic effect in severe pneumonia patients with renal dysfunction.

Objective To explore the clinical features and sum up the laws of the hepatic focal nodular hyperplasia (FNH) in its diagnosis and treatment. Methods FNH was an uncommon benign hepatic tumor that often posed diagnostic dilemmas. We analyzed retrospectively the clinical, imaging of ultrasound, imaging of computed tomography (CT) and magnetic resonance images (MRI), and pathological materials of 21 patients with FNH proven by the pathological diagnosis during 5 years from April 1996 through April 2001 in two hospitals. Results The diagnosis of FNH remained a challenge for clinicians and surgeons. Rate of correct diagnosis of FNH was low preoperatively (19.0%). The lesions of FNH were seen in males and females (m/f: 14/7). Only three female patients (3/7) had the history of taking oral contraceptive. Patients with FNH were largely young and middle age persons (81.0% under 50 years), discovered by accident (57.1%), without infection of the hepatitis B virus (95.2%) and with normal liver functions (100%) and serum AFP levels (100%). Color Doppler ultrasound showed blood vessels passing through the lesion (80.0%) and there was abundant in blood (66.7%). CT scan showed that the lesion had transient immediate enhancement in 60.0% of patients and had homogeneous signal in 60.0% after bolus injection. MR imaging demonstrated early vigorous enhancement (64.3%), homogenous signal (57.1%) and having central scar (35.7%) in the lesion. The demonstration of a central scar in the lesion was very helpful for the diagnosis of FNH. MRI was more helpful for the diagnosis of FNH using liver specific contrast agents: superparamagnetic iron oxide(SPIO). All patients underwent focus resection (18 cases) or segmentectomy (2 cases), except one having no treatment. Conclusion FNH shows some typical clinical and imaging features. We could increase the rate of correct diagnosis by comprehensively analyzing the clinical and imaging materials. It is very important and necessary to determine a definite diagnosis of FNH, hepatic adenoma (HA) and primary liver cancer (PLC) preoperatively, because the HA and PLC must be surgically resected, FNH can only be followed up.

Objectives　To study and clone a novel liver cancer related genes, and to explore the molecular basis of liver cancer genesis.　Methods　Using mRNA differential display polymerase chain reaction (DDPCR), we investigated the difference of mRNA in human hepatocellular carcinoma (HCC) and paired paracarcinoma tissue, and got a gene probe. By screening the placenta cDNA library and genomic homologous extend, we got a full-length cDNA named STW-2. We analyzed the expression of this novel gene in 42 pairs of human hepatocellular carcinoma, paracarcinoma and normal tissue by means of Northern Blot.　Results　We have got a full-length cDNA of liver cancer associated gene STW-2 submitted to GeneBank nucleotide sequence databases (Accession No. AF276707), which localized at chromosome 18p11.2. The positive expression rate of this gene was 78.6% (33/42) in hepatocellular carcinoma tissue, and the clinical pathological data showed that the STW-2 was closely related to the completion of tumor envelope and adjacant small satellite nodules lesions (P＜0.05). The STW-2 was widely distributed in human normal tissue that was highly expressed in human lunge, brain tissue, and lowerly expressed in liver tissue.　Conclusion　A novel full-length cDNA differentially expressed was obtained in liver cancer, which was closely related to the invasive and metastatic tumor, and may be the later heredited change in HCC genesis.

Objectives　To study and clone a novel liver cancer related genes, and to explore the molecular basis of liver cancer genesis.　Methods　Using mRNA differential display polymerase chain reaction (DDPCR), we investigated the difference of mRNA in human hepatocellular carcinoma (HCC) and paired paracarcinoma tissue, and got a gene probe. By screening the placenta cDNA library and genomic homologous extend, we got a full-length cDNA named STW-2. We analyzed the expression of this novel gene in 42 pairs of human hepatocellular carcinoma, paracarcinoma and normal tissue by means of Northern Blot.　Results　We have got a full-length cDNA of liver cancer associated gene STW-2 submitted to GeneBank nucleotide sequence databases (Accession No. AF276707), which localized at chromosome 18p11.2. The positive expression rate of this gene was 78.6% (33/42) in hepatocellular carcinoma tissue, and the clinical pathological data showed that the STW-2 was closely related to the completion of tumor envelope and adjacant small satellite nodules lesions (P＜0.05). The STW-2 was widely distributed in human normal tissue that was highly expressed in human lunge, brain tissue, and lowerly expressed in liver tissue.　Conclusion　A novel full-length cDNA differentially expressed was obtained in liver cancer, which was closely related to the invasive and metastatic tumor, and may be the later heredited change in HCC genesis.

Objective To evaluate the clinical efficacy of transpedicular intracorporeal bone graft with allogenic bone in treatment of thoracolumbar osteoporotic compression fracture. Methods A total of 45 patients with thoracolumbar osteoporotic compression fractures were treated with posterior short segment pedicle screw fixation and transpedicular intracorporeal bone graft with allogenic bone. Anteroposte-rior and lateral X-ray photographs were taken before and after operation and at follow up period to determine the ratio of anterior and middle compressed body height to the normal height, the vertebral angle and the superior-inferior endplate angle. The extent of local pain was measured by VAS score. The implant failure was also recorded during follow-up. Results The operative reduction and interbody bone grafting exerted a satisfactory effect on the ratio of anterior and middle body height to the normal height, the vertebral angle and the superior-inferior endplate angle. Local back pain disappeared immediately after surgery in 34 patients out of 38 patients followed up for more than two years. No implant failure was found during follow-up. Conclusions Early treatment with posterior short segment pedicle screw fixation and transpedicular intracorporeal bone graft with allogenic bone can effectively correct local deformity, prevent late vertebral collapse and implant failure and is an ideal treatment method for thoracolumbar osteoporotic compression fracture.

Objective To study the imaging distribution feature and diagnostic value of high resolution computed tomography(HRCT)in peripheral lung cancer(PLC).Methods The feature of imaging distribution was analysed in 37 patients with PLC by pathological proved,which compared with those in 23 cases with lung benign nodules by selected randomly.A double blind method was taken on the manifestations of HRCT about lung nodules tumor-lung interface in near heart side and far heart side.①cloudy or/and shaggy②spiculate③smooth.To search and define the correlation between its distributing feature;manifestations of 3 kinds HRCT;alteration of segment level bronchus and lung benign malignancy nodules.Results Cloudy,or shaggy,spiculalte departing from heart side in lung-tumor interface by HRCT were observed in peripheral lung cancer(79%) and benign nodules(22%);smooth was observed in peripheral lung cancer(14%) and benign nodules(74%).Some cases possed simultaneously two or more than two kinds HRCT's signs.Incidence rate of emphraxis and stenosis signs of segment level bronchus in PLC was higher than that in benign nodules.Conclusion Asymmetry apo-tip dominant position distribution of cloudy or shaggy,and spiculate change of tumor-lung interface by HRCT played an important role in qualitative diagnosis of peripheral lung cancer(≤3.5 cm).The appearance reason relates with the bronchial ventilation that the lesion results in occlusion.

Ion trap performances are investigated based on digital ion trap technique with different collision gases at different pressures. Collision gases of helium (4 amu), nitrogen (28 amu) and argon (40 amu) with various pressures are adopted in ion excitation and dissociation stages to investigate the ion trap performances, including mass resolution, signal intensity, tandem mass spectrometric analysis ability and low-mass cut off (LMCO) effect. It is found that when heavy gas of argon is used, energy can be efficiently transferred and LMCO effect is decreased with higher ion capture and dissociation efficiencies but with low mass resolution. Higher mass resolution is realized with helium as collision gas. Furthermore, at the same gas pressure, heavy gas is beneficial to abundant fragment ions and structural information of precursor ion.

OBJECTIVETo clone a novel liver cancer associated gene, and to explore the molecular basis of liver cancer genesis.

METHODSUsing mRNA differential display polymerase chain reaction (DDPCR) and screening the human placenta cDNA library, we got a full-length cDNA of the gene. We prepared and purified the GST fusion protein and the special polyclonal antibody, engaged in the Western blot and immunohistochemical staining analysis, and analyzed the second structures and predicted the function of the protein by the computer soft.

RESULTSWe have got a full-length cDNA of the liver cancer associated gene and identified that the full-length cDNA of the gene could be expressed in 293 eukaryocytes by Western blot assay. We localized the target protein in cytoplasm using the immunohistochemical staining methods, and found two SH3 binding domains and several protein kinase phosphorylation sites by analyzing the second structures.

CONCLUSIONSWe have got a novel full-length cDNA of human liver cancer associated gene.

Amino Acid Sequence ; Cell Line ; Cloning, Molecular ; Cytoplasm ; chemistry ; DNA, Neoplasm ; Gene Expression Profiling ; methods ; Gene Expression Regulation, Neoplastic ; Gene Library ; Humans ; Liver Neoplasms ; genetics ; Molecular Sequence Data ; Neoplasm Proteins ; biosynthesis ; chemistry ; genetics ; Nuclear Proteins ; Phosphorylation ; Polymerase Chain Reaction ; methods ; Protein Structure, Secondary ; Proteins ; chemistry ; genetics ; Recombinant Proteins ; biosynthesis ; chemistry ; genetics ; Trans-Activators ; Transcription Factors

CAR-T cell therapy has developed rapidly in recent years, and has achieved amazing results in the treatment of some malignant tumors of the blood system, but little progress has been made in the treatment of solid tumors. At present, the main problems to be solved in CAR-T cell therapy are: (1) enhancing the killing activity of CAR-T cells; (2) relieving the immunosuppressive state of tumors; (3) bringing CAR-T cells into solid tumors; (4) enhancing the safety of CAR-T cell therapy. By optimizing the structure of CAR, a series of defects in the CAR-T cell therapy can be overcome, and the curative effect of CAR-T can be enhanced and the complications can be alleviated. In this paper, some optimization and improvement measures and methods on the structure design of CAR in recent years are elaborated, and the effectiveness and safety of the CAR-T cell therapy are explored.